1.1 IDegLira, a Novel Fixed Ratio Combination of Insulin Degludec and Liraglutide, is Efficacious and Safe in Subjects with Type 2 Diabetes: A Large, Randomized Phase 3 Trial (65-OR)
Titel:
1.1 IDegLira, a Novel Fixed Ratio Combination of Insulin Degludec and Liraglutide, is Efficacious and Safe in Subjects with Type 2 Diabetes: A Large, Randomized Phase 3 Trial (65-OR)
Auteur:
Buse, John B. Gough, Stephen C. Woo, Vincent C. Rodbard, Helena W. Linjawi, Sultan Poulsen, Pernille mgaard, Lars H. Da Bode, Bruce W.